JAAD RANKS NO. 1 AMONG DERMATOLOGY JOURNALS
The Journal of the American Academy of Dermatology's impact factor remains #1 in field
JAAD's 2023 impact factor is 12.8. This places JAAD in the No. 1 position among 94 dermatology-related journals ranked by JCR in this period. A journal's impact factor is a measure of how often the average article in that journal has been cited in a given time period, which for the 2023 JCR ranking is two years (2021-22). This is the fifth straight year that JAAD has been ranked No. 1.
"We celebrate the fifth straight year as the top journal in the field, and thank our authors, reviewers, and editors for their continued high-quality work," said board-certified dermatologist
Visit JAAD.org to read the most recent research published in the journal or to submit an article for consideration.
About the AAD
Headquartered in
About JAAD
The Journal of the American Academy of Dermatology is the most widely cited dermatology journal in the world. JAAD was the top most-cited dermatology journal in 2023, according to impact factor rankings from Clarivate's Journal Citation Reports (JCR) Web of Science Group. In 2009, the Special Libraries Association named JAAD one of the most 100 influential journals of the past 100 years. JAAD also has three open-access companion titles: JAAD Case Reports, JAAD International and JAAD Reviews. Follow @JAADJournals on Facebook, Twitter and Instagram.
View original content:https://www.prnewswire.com/news-releases/jaad-ranks-no-1-among-dermatology-journals-302188123.html
SOURCE American Academy of Dermatology
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GAC Group to Celebrate 30 Million Global Users on July 16
- GeekELove Announces Launch of Dating Platform Built Around Shared Interests and Geek Culture
- Corgi Insurance Welcomes Robert E. Barlow Jr. as EVP of Partnerships to Drive Expansion in Community Association and Property & Casualty Insurance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share